Watch Ticker

Incyte Genomics Inc

Go to Incyte Genomics Inc Website

$77.31

-0.73 (-0.94%)

Live

Previous Close

$78.04

Day Range

$77.16 - $78.5

Previous Day Range

$75.48 - $78.25

Market Cap

$14.8 billion USD

Day Vol.

751414

Previous Day Vol.

1.6 million

Currency

USD

Primary Exchange

Nasdaq

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheuma...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight

The liposarcoma treatment market is driven by a rising global disease burden and growing demand for innovative therapies, including immunotherapies and targeted treatments. The pipeline features 15+ companies and 20+ therapies in various stages of development.

Related tickers: AAPG, SLRX, PFE, INCY, DSNKY.

Read Full Article

Merus N.V. - Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités

Merus reported positive interim data from its Phase II trial of petosemtamab in combination with pembrolizumab for first-line treatment of recurrent/metastatic HNSCC expressing PD-L1. The company also provided updates on its ongoing Phase III trials for petosemtamab and its collaboration programs.

Related tickers: MRUS, INCY, LLY, GILD, BHVN.

Read Full Article

Trending Tickers

Please sign in to view